The quarter was good if you knew what to look for, but it's not enough to get the average passerby to say "I've got to have this now." Next quarter? absolutely.
The stock is extremely thinly traded. That 100k share bid at 0.85 has been sitting for the last month and nobody's touched it. Longs know what they've got and are not selling. Now it just needs to be discovered.
1st Detect is easily worth the $16m market cap alone based on it's potential. The satellite processing business is probably worth around $50m (buildings alone cost $100m to construct). Stock is probably worth $4 a share conservatively. Pickens knows it which is why he now owns 20% of the company. If Astrogenetix has a breakthrough, $20 or $30 is not out of the question...that would only be a $400-500m market cap for a drug that would do billions in revenue.